Clinical Trial Update: Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED) [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial evaluating the efficacy and safety of MK0928 for insomnia in adults. It summarizes the trial's outcomes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• MK0928

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Insomnia | Phase 3 | Status: COMPLETED